News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,363 Results
Type
Article (1514)
Company Profile (7)
Press Release (44841)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (16508)
Career Advice (22)
Deals (3234)
Drug Delivery (7)
Drug Development (3848)
Employer Resources (8)
FDA (690)
Job Trends (860)
News (21754)
Policy (1760)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 Pharm Country Standard (1)
Academia (94)
Accelerated approval (2)
ADA (1)
Allergies (1)
Alliances (3260)
ALS (10)
Alzheimer's disease (125)
Antibody-drug conjugate (ADC) (29)
Approvals (731)
Artificial intelligence (65)
ASCO (14)
Autoimmune disease (37)
Automation (1)
Bankruptcy (27)
Belgium (12)
Best Places to Work (506)
BIO (6)
Biologics (3)
Biosimilars (23)
BioSpace Insights (4)
Biotechnology (17)
Bispecific (2)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (88)
Cancer (395)
Cardiovascular disease (12)
Career advice (23)
CAR-T (15)
CDC (1)
CDMO (7)
Cell therapy (47)
Cervical cancer (1)
Clinical research (3309)
Collaboration (160)
Commercialization (3)
Compensation (22)
Complete response letters (2)
COVID-19 (247)
CRISPR (7)
C-suite (100)
Cystic fibrosis (3)
Data (451)
Denatured (1)
Depression (9)
Dermatology (7)
Diabetes (15)
Diagnostics (510)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (45)
Drug pricing (3)
Duchenne muscular dystrophy (5)
Earnings (5291)
Employer resources (7)
ESMO (20)
Events (6163)
Executive appointments (90)
FDA (889)
Fragile X (3)
Funding (140)
Gene editing (11)
Generative AI (2)
Gene therapy (22)
GLP-1 (32)
Government (162)
Guidances (19)
Healthcare (1191)
Hematology (6)
HIV (1)
Huntington's disease (5)
IgA nephropathy (4)
Immunology and inflammation (7)
Immuno-oncology (3)
Indications (13)
Infectious disease (261)
Inflammatory bowel disease (7)
Influenza (2)
Intellectual property (12)
Interviews (5)
IPO (1241)
IRA (2)
Job creations (355)
Job search strategy (19)
JPM (4)
Kidney cancer (1)
Kidney disease (6)
Labor market (2)
Layoffs (25)
Leadership (1)
Legal (689)
Licensing (2)
Liver cancer (1)
Longevity (2)
Lung cancer (30)
Lymphoma (17)
Machine learning (7)
Management (4)
Manufacturing (69)
Marketing (1)
MASH (2)
Medical affairs (1)
Medical device (867)
Medtech (880)
Melanoma (3)
Mergers & acquisitions (2132)
Metabolic disorders (24)
mRNA (10)
Multiple sclerosis (6)
Netherlands (1)
Neurodegenerative disease (18)
Neuropsychiatric disorders (2)
Neuroscience (190)
NextGen: Class of 2026 (359)
Non-profit (172)
Now hiring (7)
Obesity (6)
Opinion (4)
Ovarian cancer (4)
Pain (16)
Pancreatic cancer (29)
Parkinson's disease (11)
Partnered (15)
Patents (36)
Patient recruitment (35)
Patient selection (7)
People (5039)
Peptides (3)
Pharmaceutical (4)
Phase 1 (1095)
Phase 2 (1607)
Phase 3 (951)
Pipeline (584)
Policy (5)
Postmarket research (89)
Preclinical (528)
Press Release (2)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (37)
Rare diseases (56)
Real estate (426)
Recruiting (3)
Regenerative medicine (2)
Regulatory (1183)
Reports (29)
Research institute (94)
Rett syndrome (8)
RNA editing (3)
RSV (1)
Schizophrenia (5)
Series A (16)
Series B (6)
Service/supplier (2)
Sickle cell disease (3)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (272)
State (1)
Stem cells (1)
Supply chain (4)
Tariffs (1)
Vaccines (42)
Venture capital (3)
Weight loss (3)
Women's health (4)
Date
Last 7 days (41)
Last 30 days (201)
Last 365 days (1887)
2026 (1722)
2025 (1961)
2024 (2280)
2023 (2595)
2022 (3498)
2021 (4218)
2020 (3325)
2019 (2440)
2018 (1944)
2017 (1728)
2016 (1696)
2015 (2055)
2014 (1673)
2013 (1441)
2012 (1615)
2011 (1633)
2010 (1704)
Location
Africa (48)
Alabama (3)
Arizona (16)
Asia (1749)
Australia (214)
California (519)
Canada (1351)
China (61)
Colorado (22)
Connecticut (60)
Delaware (20)
Europe (3676)
Florida (132)
Georgia (11)
Idaho (3)
Illinois (69)
India (7)
Indiana (66)
Iowa (1)
Japan (38)
Kansas (3)
Kentucky (3)
Louisiana (4)
Maryland (46)
Massachusetts (427)
Michigan (59)
Minnesota (89)
Missouri (1)
Montana (10)
Nebraska (3)
Nevada (10)
New Hampshire (11)
New Jersey (323)
New Mexico (7)
New York (273)
North Carolina (107)
North Dakota (1)
Northern California (275)
Ohio (24)
Oklahoma (6)
Oregon (3)
Pennsylvania (256)
Puerto Rico (1)
South America (62)
South Carolina (1)
Southern California (158)
Tennessee (16)
Texas (271)
United States (2852)
Utah (6)
Vermont (1)
Virginia (13)
Washington D.C. (2)
Washington State (34)
Wisconsin (47)
Wyoming (3)
46,363 Results for "kinetic river corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
August 20, 2026
·
5 min read
Press Releases
Charles River Laboratories Announces Third-Quarter 2026 Results
November 4, 2026
·
19 min read
Press Releases
Charles River Laboratories to Present at Jefferies Global Healthcare Conference 2026
November 16, 2026
·
1 min read
Press Releases
Charles River Leverages Virtual Control Groups in GLP Studies
October 27, 2026
·
3 min read
Press Releases
Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses
November 9, 2026
·
13 min read
Press Releases
Alpheus Presents Data on Serial LDH Kinetics as a Potential Blood-Based Biomarker in Glioblastoma
October 27, 2026
·
3 min read
Press Releases
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
October 6, 2026
·
4 min read
Press Releases
Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
November 12, 2026
·
5 min read
Press Releases
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
October 9, 2026
·
1 min read
Press Releases
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
October 23, 2026
·
2 min read
1 of 4,637
Next